Search

Experience Spotlight

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

The Healthcare Fraud & Abuse Review 2017 details all healthcare-related False Claims Act settlements from last year, organized by particular sectors of the healthcare industry. In addition to reviewing all healthcare fraud-related settlements, the Review includes updates on enforcement-related litigation involving the Stark Law and Anti-Kickback Statute, and looks at the continued implications from the government's focus on enforcement efforts involving individual actors in connection with civil and criminal healthcare fraud investigations.

(202) 380-0842 FAX

(202) 380-0842 FAX

As co-chair of the firm's Intellectual Property & Technology Practice Group, Janelle Waack brings with her more than 20 years of experience focused on the strategic, cost-effective management of IP litigation, patent procurement and specialty proceedings before the USPTO Patent Trial and Appeal Board (PTAB). Her clients span technology sectors, including pharmaceuticals, chemistry, agricultural products, biotechnology, medical diagnostics, medical devices, genetically engineered crops, stem cell technology, veterinary products, retail, omnichannel marketing, software and unmanned vehicles. She is a registered U.S. patent attorney with a degree in chemical engineering and served as a former Patent Examiner at the U.S. Patent and Trademark Office in the biotechnology, medical diagnostics and medical device art units.

As co-chair of the firm's Intellectual Property & Technology Practice Group, Janelle Waack brings with her more than 20 years of experience focused on the strategic, cost-effective management of IP litigation, patent procurement and specialty proceedings before the USPTO Patent Trial and Appeal Board (PTAB). Her clients span technology sectors, including pharmaceuticals, chemistry, agricultural products, biotechnology, medical diagnostics, medical devices, genetically engineered crops, stem cell technology, veterinary products, retail, omnichannel marketing, software and unmanned vehicles. She is a registered U.S. patent attorney with a degree in chemical engineering and served as a former Patent Examiner at the U.S. Patent and Trademark Office in the biotechnology, medical diagnostics and medical device art units.

Janelle has managed IP due diligence reviews for corporate, product, and patent portfolio acquisitions of up to $2.6 billion, providing patent related opinions and advising clients on the strategic development and licensing of patent portfolios. She has served as lead counsel for numerous contested cases before the PTAB and prevailed in complex, multi-party and multi-jurisdiction disputes including actions before district courts and the Federal Circuit. She has extensive experience in patent interference matters, representing clients on issues of patentability, priority of invention, inventorship, and ownership. She also handles derivation proceedings, inter partes reviews, post grant reviews, and the post-grant correction of patents via reissue and reexamination procedures. Her work on the reissuance of a key patent in the agriculture biotechnology industry and associated trial testimony recently led to a $1 billion verdict for her client.

Her practice includes:

Patent Litigation – Representing clients in patent infringement, trade secret, patent validity and contract disputes in district courts and the Federal Circuit, and coordinating concurrent or multiple proceedings in the USPTO related to the same patents.

Intellectual Property Portfolio Review – Conducting due diligence reviews of patent and other IP assets and advising clients on the strategic worldwide development and licensing of patent portfolios.

Regulatory and Compliance – Monitoring ongoing developments in emerging technologies and advising clients on regulatory requirements in areas such as biologics and biosimilars, genetically engineered crops, as well as omnichannel marketing and unmanned systems (including FAA Section 333 exemptions).

Before joining Bass, Berry & Sims, Janelle worked as a Patent Examiner in the biotechnology, medical diagnostics and medical device art units at the USPTO, as a partner at national and IP boutique firms in Texas, and as a patent agent at a Washington D.C. law firm.

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.